Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Granger

Showing results (161-170 of 910) with videos related to

Pageof 91
Sort By:
American Heart Journal|July 31, 2013
The forgotten lead: does aVR ST-deviation add insight into the outcomes of ST-elevation myocardial infarction patients?Aws Alherbish, Cynthia M Westerhout, Yuling Fu, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|September 3, 2013
Alcohol withdrawal prevention: a randomized evaluation of lorazepam and ethanol--a pilot studyJoyce E Fullwood, Zhila Mostaghimi, Christopher B Granger, et al.
American Heart Journal|May 28, 2013
Cardiovascular clinical research in South AmericaJosé C Nicolau, Ramon Corbalan, Rafael Diaz, et al.
The American Journal of Cardiology|May 21, 2008
The editor's roundtable: management and treatment of non-ST-segment elevation in acute coronary syndromesWilliam C Roberts, Christopher B Granger, Manesh R Patel, et al.
American Heart Journal|May 28, 2013
Rescuing clinical trials in the United States and beyond: a call for actionZubin J Eapen, John P Vavalle, Christopher B Granger, et al.
American Heart Journal|October 31, 2006
Reperfusion of acute myocardial infarction in North Carolina emergency departments (RACE): study designJames G Jollis, Rajendra H Mehta, Mayme Lou Roettig, et al.
European Heart Journal|April 26, 2007
Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromesSunil V Rao, John A Eikelboom, Christopher B Granger, et al.
American Heart Journal|July 17, 2012
Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trialCatherine Martel, Christopher B Granger, Marta Ghitescu, et al.
JACC. Cardiovascular Interventions|March 20, 2010
Mortality and morbidity reduction by primary percutaneous coronary intervention is independent of the patient's ageSanneke P M de Boer, Cynthia M Westerhout, R John Simes, et al.
Journal of Cardiac Failure|June 8, 2020
Changes in Care Delivery for Patients With Heart Failure During the COVID-19 Pandemic: Results of a Multicenter SurveyColleen K McIlvennan, Larry A Allen, Adam D Devore, et al.
Pageof 91

Showing results (161-170 of 910) with videos related to

Sort By:
Pageof 91
American Heart Journal|July 31, 2013
The forgotten lead: does aVR ST-deviation add insight into the outcomes of ST-elevation myocardial infarction patients?Aws Alherbish, Cynthia M Westerhout, Yuling Fu, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|September 3, 2013
Alcohol withdrawal prevention: a randomized evaluation of lorazepam and ethanol--a pilot studyJoyce E Fullwood, Zhila Mostaghimi, Christopher B Granger, et al.
American Heart Journal|May 28, 2013
Cardiovascular clinical research in South AmericaJosé C Nicolau, Ramon Corbalan, Rafael Diaz, et al.
The American Journal of Cardiology|May 21, 2008
The editor's roundtable: management and treatment of non-ST-segment elevation in acute coronary syndromesWilliam C Roberts, Christopher B Granger, Manesh R Patel, et al.
American Heart Journal|May 28, 2013
Rescuing clinical trials in the United States and beyond: a call for actionZubin J Eapen, John P Vavalle, Christopher B Granger, et al.
American Heart Journal|October 31, 2006
Reperfusion of acute myocardial infarction in North Carolina emergency departments (RACE): study designJames G Jollis, Rajendra H Mehta, Mayme Lou Roettig, et al.
European Heart Journal|April 26, 2007
Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromesSunil V Rao, John A Eikelboom, Christopher B Granger, et al.
American Heart Journal|July 17, 2012
Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trialCatherine Martel, Christopher B Granger, Marta Ghitescu, et al.
JACC. Cardiovascular Interventions|March 20, 2010
Mortality and morbidity reduction by primary percutaneous coronary intervention is independent of the patient's ageSanneke P M de Boer, Cynthia M Westerhout, R John Simes, et al.
Journal of Cardiac Failure|June 8, 2020
Changes in Care Delivery for Patients With Heart Failure During the COVID-19 Pandemic: Results of a Multicenter SurveyColleen K McIlvennan, Larry A Allen, Adam D Devore, et al.
Pageof 91